Non-Surgical Chemotherapeutic Treatment Strategies for the Management of Periodontal Diseases

Dental Clinics of North America

Volumn 54, Issue 1, 2010, Pages 13-33

  Krayer, Joe W ^a   Leite, Renata S ^a   Kirkwood, Keith L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antibiotics; Antiseptics; Host modulatory agent; Periodontics

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; LISTERINE; MATRIX METALLOPROTEINASE; MOUTHWASH; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SALICYLIC ACID DERIVATIVE; TERPENE; TOPICAL ANTIINFECTIVE AGENT;

CHRONIC PERIODONTITIS; DRUG ANTAGONISM; DRUG APPROVAL; DRUG COMBINATION; DRUG EFFECT; GINGIVITIS; HUMAN; IMMUNOMODULATION; MEDICAL SOCIETY; ORAL DRUG ADMINISTRATION; REVIEW; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION; UNITED STATES;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AMERICAN DENTAL ASSOCIATION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHLORHEXIDINE; CHRONIC PERIODONTITIS; DENTAL PLAQUE; DRUG APPROVAL; DRUG COMBINATIONS; GINGIVITIS; HUMANS; IMMUNOMODULATION; MATRIX METALLOPROTEINASES; MOUTHWASHES; PROSTAGLANDIN ANTAGONISTS; SALICYLATES; TERPENES; UNITED STATES;

EID: 73249115526     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2009.08.010     Document Type: Review

References (83)

1. Socransky S.S., and Haffajee A.D. Evidence of bacterial etiology: a historical perspective. Periodontol 2000 5 (1994) 7-25
2. Kirkwood K.L., Cirelli J.A., Rogers J.E., et al. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 43 (2007) 294-315
3. Baelum V., and Fejerskov O. Tooth loss as related to dental caries and periodontal breakdown in adult Tanzanians. Community Dent Oral Epidemiol 14 6 (1986) 353-357
4. Baelum V., Wen-Min L., Fejerskov O., et al. Tooth mortality and periodontal conditions in 60-80-year-old Chinese. Scand J Dent Res 96 2 (1988) 99-107
5. Loe H., Anerud A., Boysen H., et al. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 13 5 (1986) 431-445
6. Feller L., and Lemmer J. Necrotizing periodontal diseases in HIV-seropositive subjects: pathogenic mechanisms. J Int Acad Periodontol 10 1 (2008) 10-15
7. Mealey B.L. Impact of advances in diabetes care on dental treatment of the diabetic patient. Compend Contin Educ Dent 19 1 (1998) 41-44 6-8, 50 passim [quiz 60]
8. Socransky S.S., and Haffajee A.D. Periodontal microbial ecology. Periodontol 2000 38 (2005) 135-187
9. Knoll-Kohler E. Metronidazole dental gel as an alternative to scaling and root planing in the treatment of localized adult periodontitis. Is its efficacy proved?. Eur J Oral Sci 107 6 (1999) 415-421
10. Slots J., and Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 28 (2002) 106-176
11. Ng V.W., and Bissada N.F. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 69 7 (1998) 772-776
12. Winkel E.G., Van Winkelhoff A.J., Timmerman M.F., et al. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 28 4 (2001) 296-305
13. Watts T., Palmer R., and Floyd P. Metronidazole: a double-blind trial in untreated human periodontal disease. J Clin Periodontol 13 10 (1986) 939-943
14. Lopez N.J., Gamonal J.A., and Martinez B. Repeated metronidazole and amoxicillin treatment of periodontitis. A follow-up study. J Periodontol 71 1 (2000) 79-89
15. Loesche W.J., Giordano J.R., Hujoel P., et al. Metronidazole in periodontitis: reduced need for surgery. J Clin Periodontol 19 2 (1992) 103-112
16. Loesche W.J., Syed S.A., Morrison E.C., et al. Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks. J Periodontol 55 6 (1984) 325-335
17. Elter J.R., Lawrence H.P., Offenbacher S., et al. Meta-analysis of the effect of systemic metronidazole as an adjunct to scaling and root planing for adult periodontitis. J Periodontal Res 32 6 (1997) 487-496
18. Sigusch B., Beier M., Klinger G., et al. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J Periodontol 72 3 (2001) 275-283
19. Gomi K., Yashima A., Nagano T., et al. Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin. J Periodontol 78 3 (2007) 422-429
20. Dastoor S.F., Travan S., Neiva R.F., et al. Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: a pilot study. J Periodontol 78 10 (2007) 1887-1896
21. Cionca N., Giannopoulou C., Ugolotti G., et al. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. J Periodontol 80 3 (2009) 364-371
22. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 10 (1996) 79-88
23. Bonito A.J., Lux L., and Lohr K.N. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 76 8 (2005) 1227-1236
24. Goodson J.M., Cugini M.A., Kent R.L., et al. Multicenter evaluation of tetracycline fiber therapy: II. Clinical response. J Periodontal Res 26 4 (1991) 371-379
25. Garrett S., Johnson L., Drisko C.H., et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 70 5 (1999) 490-503
26. Wennstrom J.L., Newman H.N., MacNeill S.R., et al. Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. A comparative multi-centre trial of 2 treatment approaches. J Clin Periodontol 28 8 (2001) 753-761
27. Machion L., Andia D.C., Lecio G., et al. Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-up. J Periodontol 77 4 (2006) 606-613
28. Williams R.C., Paquette D.W., Offenbacher S., et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol 72 11 (2001) 1535-1544
29. Goodson J.M., Gunsolley J.C., Grossi S.G., et al. Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy. J Periodontol 78 8 (2007) 1568-1579
30. Ainamo J., Lie T., Ellingsen B.H., et al. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 19 9 Pt 2 (1992) 723-729
31. Pradeep A.R., Sagar S.V., and Daisy H. Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 79 11 (2008) 2125-2135
32. Ciancio S. Non-surgical periodontal treatment. Proceedings of the World Workshop in Clinical Periodontics. 1989. p. II:II1-12.
33. Addy M. Oral hygiene products: potential for harm to oral and systemic health?. Periodontol 2000 48 1 (2008) 54-65
34. Fornell J., Sundin Y., and Lindhe J. Effect of Listerine on dental plaque and gingivitis. Scand J Dent Res 83 1 (1975) 18-25
35. DePaola L.G., Overholser C.D., Meiller T.F., et al. Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development. J Clin Periodontol 16 5 (1989) 311-315
36. Gordon J.M., Lamster I.B., and Seiger M.C. Efficacy of Listerine antiseptic in inhibiting the development of plaque and gingivitis. J Clin Periodontol 12 8 (1985) 697-704
37. Loe H., and Schiott C.R. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res 5 2 (1970) 79-83
38. Flotra L., Gjermo P., Rolla G., et al. 4-Month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scand J Dent Res 80 1 (1972) 10-17
39. Overholser C.D., Meiller T.F., DePaola L.G., et al. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 17 8 (1990) 575-579
40. Kim Y.J., Rossa Jr. C., and Kirkwood K.L. Prostaglandin production by human gingival fibroblasts inhibited by triclosan in the presence of cetylpyridinium chloride. J Periodontol 76 10 (2005) 1735-1742
41. Pires J.R., Rossa C.J., and Pizzolitto A.C. In vitro antimicrobial efficiency of a mouthwash containing Triclosan/Gantrez and sodium bicarbonate. Braz Oral Res 21 4 (2007) 342-347
42. Yazdankhah S.P., Scheie A.A., Hoiby E.A., et al. Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist 12 2 (2006) 83-90
43. Walker C., Borden L.C., Zambon J.J., et al. The effects of a 0.3% triclosan-containing dentifrice on the microbial composition of supragingival plaque. J Clin Periodontol 21 5 (1994) 334-341
44. Jones C.L., Ritchie J.A., Marsh P.D., et al. The effect of long-term use of a dentifrice containing zinc citrate and a non-ionic agent on the oral flora. J Dent Res 67 1 (1988) 46-50
45. Gusberti F.A., Sampathkumar P., Siegrist B.E., et al. Microbiological and clinical effects of chlorhexidine digluconate and hydrogen peroxide mouthrinses on developing plaque and gingivitis. J Clin Periodontol 15 1 (1988) 60-67
46. Weitzman S.A., Weitberg A.B., Niederman R., et al. Chronic treatment with hydrogen peroxide. Is it safe?. J Periodontol 55 9 (1984) 510-511
47. Siegrist B., Gusberti F., Brecx M., et al. Efficacy of supervised rinsing with chlorhexidine digluconate in comparison to phenolic and plant alkaloid compounds. J Periodontal Res 21 Suppl 16 (1986) 60
48. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1 1 (1996) 821-878
49. Greenwell H. Position paper. Guidelines for periodontal therapy. J Periodontol 72 11 (2001) 1624-1628
50. Reddy M.S., Geurs N.C., and Gunsolley J.C. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 8 1 (2003) 12-37
51. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 28 6 Pt 2 (1993) 500-510
52. Golub L.M., Goodson J.M., Lee H.M., et al. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. J Periodontol 56 Suppl 11 (1985) 93-97
53. Burns F.R., Stack M.S., Gray R.D., et al. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 30 7 (1989) 1569-1575
54. Golub L.M., Ciancio S., Ramamamurthy N.S., et al. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 25 6 (1990) 321-330
55. DeWitt D.L., Meade E.A., and Smith W.L. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 95 2A (1993) 40S-44S
56. Dewhirst F.E., Moss D.E., Offenbacher S., et al. Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. J Periodontal Res 18 2 (1983) 156-163
57. Offenbacher S., Farr D.H., and Goodson J.M. Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol 8 4 (1981) 359-367
58. Shimizu N., Ozawa Y., Yamaguchi M., et al. Induction of COX-2 expression by mechanical tension force in human periodontal ligament cells. J Periodontol 69 6 (1998) 670-677
59. Holzhausen M., Rossa Junior C., Marcantonio Junior E., et al. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 73 9 (2002) 1030-1036
60. Holzhausen M., Spolidorio D.M., Muscara M.N., et al. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res 40 3 (2005) 208-211
61. Bezerra M.M., de Lima V., Alencar V.B., et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 71 6 (2000) 1009-1014
62. Rogers M.J., Gordon S., Benford H.L., et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88 Suppl 12 (2000) 2961-2978
63. Fleisch H.A. Bisphosphonates: preclinical aspects and use in osteoporosis. Ann Med 29 1 (1997) 55-62
64. Brunsvold M.A., Chaves E.S., Kornman K.S., et al. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 63 10 (1992) 825-830
65. Reddy M.S., Weatherford III T.W., Smith C.A., et al. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 66 3 (1995) 211-217
66. Rocha M., Nava L.E., Vazquez de la Torre C., et al. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial. J Periodontol 72 2 (2001) 204-209
67. Rocha M.L., Malacara J.M., Sanchez-Marin F.J., et al. Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial. J Periodontol 75 12 (2004) 1579-1585
68. Lane N., Armitage G.C., Loomer P., et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 76 7 (2005) 1113-1122
69. Jeffcoat M.K., Cizza G., Shih W.J., et al. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 9 3 (2007) 70-76
70. El-Shinnawi U.M., and El-Tantawy S.I. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 5 1 (2003) 5-10
71. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 9 (2003) 1115-1117
72. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 5 (2004) 527-534
73. Odvina C.V., Zerwekh J.E., Rao D.S., et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90 3 (2005) 1294-1301
74. Caton J.G., Ciancio S.G., Blieden T.M., et al. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Periodontol 28 8 (2001) 782-789
75. Gapski R., Barr J.L., Sarment D.P., et al. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J Periodontol 75 3 (2004) 441-452
76. Chang K.M., Ryan M.E., Golub L.M., et al. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy. Res Commun Mol Pathol Pharmacol 91 3 (1996) 303-318
77. Novak M.J., Johns L.P., Miller R.C., et al. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol 73 7 (2002) 762-769
78. Golub L.M., McNamara T.F., Ryan M.E., et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 28 2 (2001) 146-156
79. Assuma R., Oates T., Cochran D., et al. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 160 1 (1998) 403-409
80. Graves D.T., Delima A.J., Assuma R., et al. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 69 12 (1998) 1419-1425
81. Adams J.L., Badger A.M., Kumar S., et al. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 38 (2001) 1-60
82. Kumar S., Votta B.J., Rieman D.J., et al. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol 187 3 (2001) 294-303
83. Rogers J.E., Li F., Coatney D.D., et al. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J Periodontol 78 10 (2007) 1992-1998